Piroxicam reverses endotoxin-induced hypotension in rats: contribution of vasoactive eicosanoids and nitric oxide

Basic Clin Pharmacol Toxicol. 2011 Sep;109(3):186-94. doi: 10.1111/j.1742-7843.2011.00708.x. Epub 2011 May 6.

Abstract

Nitric oxide (NO) produced by inducible NO synthase (iNOS) is responsible for endotoxin-induced vascular hyporeactivity and hypotension resulting in multiple organ failure. Endotoxic shock is also characterized by decreased expression of constitutive cyclooxygenase (COX-1), cytochrome P450 (CYP) 4A and endothelial NOS (eNOS). Our previous studies demonstrated that dual inhibition of iNOS and COX with a selective COX-2 inhibitor, NS-398, or a non-selective COX inhibitor, indomethacin, restores blood pressure presumably because of increased production of 20-hydroxyeicosatetraenoic acid (20-HETE) derived from arachidonic acid (AA) by CYP4A in endotoxaemic rats. The aim of this study was to investigate the effects of piroxicam, a preferential COX-1 inhibitor, on the endotoxin-induced changes in blood pressure, expression of COX-1, inducible COX (COX-2), CYP4A1, eNOS, iNOS and heat shock protein 90 (hsp90), and production of PGI(2), PGE(2), 20-HETE and NO. Injection of endotoxin (10 mg/kg, i.p.) to male Wistar rats caused a fall in blood pressure and an increase in heart rate associated with elevated renal 6-keto-PGF(1α) and PGE(2) levels as well as an increase in COX-2 protein expression. Endotoxin also caused an elevation in systemic and renal nitrite levels associated with increased renal iNOS protein expression. In contrast, systemic and renal 20-HETE levels and renal expression of eNOS, COX-1 and CYP4A1 were decreased in endotoxaemic rats. The effects of endotoxin, except for renal COX-1 and eNOS protein expression, were prevented by piroxicam (10 mg/kg, i.p.), given 1 hr after injection of endotoxin. Endotoxin did not change renal hsp90 protein expression. These data suggest that a decrease in the expression and activity of COX-2 and iNOS associated with an increase in CYP4A1 expression and 20-HETE synthesis contributes to the effect of piroxicam to prevent the hypotension during rat endotoxaemia.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Blood Pressure / drug effects
  • Cyclooxygenase 1 / metabolism
  • Cyclooxygenase 2 / metabolism
  • Cyclooxygenase Inhibitors / administration & dosage
  • Cyclooxygenase Inhibitors / pharmacology
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Cytochrome P-450 CYP4A / biosynthesis
  • Dinoprostone / biosynthesis
  • Eicosanoids / biosynthesis*
  • Endotoxins / toxicity*
  • Epoprostenol / biosynthesis
  • Hydroxyeicosatetraenoic Acids / biosynthesis
  • Hypotension / chemically induced
  • Hypotension / enzymology
  • Hypotension / metabolism
  • Hypotension / prevention & control*
  • Male
  • Nitric Oxide / biosynthesis*
  • Nitric Oxide Synthase Type II / antagonists & inhibitors
  • Piroxicam / administration & dosage
  • Piroxicam / pharmacology
  • Piroxicam / therapeutic use*
  • Rats
  • Rats, Wistar
  • Time Factors
  • Vasoconstriction / drug effects
  • Vasodilation / drug effects

Substances

  • Cyclooxygenase Inhibitors
  • Eicosanoids
  • Endotoxins
  • Hydroxyeicosatetraenoic Acids
  • Piroxicam
  • Nitric Oxide
  • endotoxin, Escherichia coli
  • 20-hydroxy-5,8,11,14-eicosatetraenoic acid
  • Epoprostenol
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
  • Cytochrome P-450 CYP4A
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Dinoprostone